Antibe Therapeutics Inc. (T.ATE) hit a new 52-week high of 73 cents Wednesday. Antibe announced the completion of the pharmacokinetic/pharmacodynamic study of otenaproxesul’s faster-absorbing formulation for acute pain. The study was designed to confirm the drug’s safety and inform treatment regimens for the upcoming Phase II trial, on track to launch in calendar Q1 2024.
Alimentation Couche-Tard Inc. (T.ATD) hit a new 52-week high of $76.72 Wednesday. No news stories available today.
Cameco Corporation (T.CCO) hit a new 52-week high of $57.01 Wednesday.
Enterprise Group Inc. (T.E) hit a new 52-week high of 66 cents Wednesday. No news stories available today.
Empire Company Limited (T.EMP.A) hit a new 52-week high of $38.50 Wednesday. No news stories available today.
1CM Inc. (C.EPIC) hit a new 52-week high of $2.29 Wednesday. No news stories available today.
H2O Innovation Inc. (T.HEO) hit a new 52-week high of $4.23 Wednesday. No news stories available today.
Kelt Exploration Ltd. (T.KEL) hit a new 52-week high of $7.94 Wednesday. No news stories available today.
Parkland Corporation (T.PKI) hit a new 52-week high of $42.69 Wednesday. No news stories available today.
Stella-Jones Inc. (T.SJ) hit a new 52-week high of $73.13 Wednesday. No news stories available today.
Tenaz Energy Corp. (T.TNZ) hit a new 52-week high of $4.40 Wednesday. No news stories available today.
Valeura Energy Inc. (T.VLE) hit a new 52-week high of $4.02 Wednesday. No news stories available today.
